RYANAIR HOLD. PLC And 3 Other Stocks Have High Sales Growth And An Above 3% Return on Equity

(VIANEWS) – RYANAIR HOLD. PLC (RYA.IR), SPBK1 ØSTFOLD AKE (SOAG.OL), NAVAMEDIC (NAVA.OL) are the highest sales growth and return on equity stocks on this list.

Here is a list of stocks with an above 5% expected next quarter sales growth, and a 3% or higher return on equity. May these stocks be a good medium-term investment option?

1. RYANAIR HOLD. PLC (RYA.IR)

38.7% sales growth and 23.49% return on equity

Ryanair Holdings plc, together with its subsidiaries, provides scheduled-passenger airline services in Ireland, the United Kingdom, Italy, Spain, Germany, and other European countries. It is also involved in the provision of various ancillary services, such as non-flight scheduled and Internet-related services; in-flight sale of beverages, food, duty-free, and merchandise; and marketing of car hire and accommodation services, and travel insurance through its website and mobile app. In addition, the company offers aircraft and passenger handling, ticketing, and maintenance and repair services; and markets car parking, fast-track, airport transfers, attractions, and activities on its website and mobile app, as well as sells gift vouchers. As of June 30, 2022, it had a principal fleet of approximately 483 Boeing 737 aircrafts and 29 Airbus A320 aircrafts; and offered approximately 3,000 short-haul flights per day serving approximately 225 airports. Ryanair Holdings plc was founded in 1985 and is headquartered in Swords, Ireland.

Earnings Per Share

As for profitability, RYANAIR HOLD. PLC has a trailing twelve months EPS of €1.13.

PE Ratio

RYANAIR HOLD. PLC has a trailing twelve months price to earnings ratio of 14.59. Meaning, the purchaser of the share is investing €14.59 for every euro of annual earnings.

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 23.49%.

Earnings Before Interest, Taxes, Depreciation, and Amortization

RYANAIR HOLD. PLC’s EBITDA is 316.68.

Sales Growth

RYANAIR HOLD. PLC’s sales growth for the next quarter is 38.7%.

Yearly Top and Bottom Value

RYANAIR HOLD. PLC’s stock is valued at €16.49 at 02:20 EST, under its 52-week high of €17.40 and way above its 52-week low of €10.09.

Moving Average

RYANAIR HOLD. PLC’s worth is under its 50-day moving average of €16.61 and way above its 200-day moving average of €14.68.

More news about RYANAIR HOLD. PLC.

2. SPBK1 ØSTFOLD AKE (SOAG.OL)

36.1% sales growth and 11.66% return on equity

SpareBank 1 Østfold Akershus, a savings bank, provides various banking products and services in Østfold and the southern part of Akershus. The company offers savings, operating, tax deduction, deposit, placement, and currency accounts; and savings and investment products. It also provides consumer, construction, repayment, boat, motorcycle, and car loans; operating credit products; bank guarantees; liquidity loans with government guarantees; operating credit for agriculture; mortgage products; leasing and factoring services; and refinancing services. In addition, the company offers various insurance products, such as vehicle, house and travel, personal, animal, liability, work machine, interruption, condominium, cyber, truck, movable property, commercial building, project, transport, crime, bus, group life, health, leisure accident, occupational injury, accident insurance children, and sick pay insurance products; and pension products. Further, it provides credit, municipal payment, and other bank cards; payment terminal, debt collection, and document collection services; bonds, forwards, and currency options; accounting approved, invoice automatic, eGiro/Cremul, KID invoice, and OCR and eGiro payment services; and mobile and online banking services. The company was founded in 1835 and is headquartered in Moss, Norway.

Earnings Per Share

As for profitability, SPBK1 ØSTFOLD AKE has a trailing twelve months EPS of kr35.74.

PE Ratio

SPBK1 ØSTFOLD AKE has a trailing twelve months price to earnings ratio of 8.56. Meaning, the purchaser of the share is investing kr8.56 for every norwegian krone of annual earnings.

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 11.66%.

Yearly Top and Bottom Value

SPBK1 ØSTFOLD AKE’s stock is valued at kr306.00 at 02:20 EST, way below its 52-week high of kr348.00 and higher than its 52-week low of kr280.00.

More news about SPBK1 ØSTFOLD AKE.

3. NAVAMEDIC (NAVA.OL)

22.8% sales growth and 22.97% return on equity

Navamedic ASA, a pharmaceutical company, develops, produces, markets, and sells pharmaceuticals and related products in Northern Europe. The company's product portfolio includes prescription and non-prescription pharmaceuticals, as well as medical nutrition products, medical devices, food supplements, and cosmetics. It offers medical nutrition products for various therapeutic areas, including phenylketonuria, homocystinuria, maple syrup urine disease, tyrosinemia, methylmalonic acidemia/propionic acidemia, glutaric aciduria, isovaleric acidemia, and urea cycle disorders, as well as products for glycogen storage diseases and renal diseases, fat metabolism, malnutrition, and ketogenic diet. In addition, the company provides consumer health products consisting of non-prescription drugs and health care products for pain relief, cough and cold, gastro, obesity, women's health, and others primarily through pharmacies and drugstores; specialty pharmaceutical products in various therapeutic areas comprising dermatology, wound care, urology, and obesity; and branded generics, including cardiology products and antibiotics. It sells, markets, and distributes its products to hospitals, patients, and pharmacies. The company was formerly known as Glucomed AS and changed its name to Navamedic ASA in 2004. Navamedic ASA was incorporated in 2002 and is headquartered in Oslo, Norway.

Earnings Per Share

As for profitability, NAVAMEDIC has a trailing twelve months EPS of kr1.73.

PE Ratio

NAVAMEDIC has a trailing twelve months price to earnings ratio of 21.56. Meaning, the purchaser of the share is investing kr21.56 for every norwegian krone of annual earnings.

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 22.97%.

Volume

Today’s last reported volume for NAVAMEDIC is 19459 which is 30.75% below its average volume of 28101.

Revenue Growth

Year-on-year quarterly revenue growth grew by 93.3%, now sitting on 440.93M for the twelve trailing months.

Sales Growth

NAVAMEDIC’s sales growth is 11.5% for the present quarter and 22.8% for the next.

More news about NAVAMEDIC.

4. AKER SOLUTIONS (AKSO.OL)

14.2% sales growth and 17.09% return on equity

Aker Solutions ASA provides solutions, products, systems, and services to the oil and gas industry worldwide. It offers field planning, feasibility, and concept studies; specialist engineering, project management, and procurement services; floater designs, offshore wind, as well as engages in design, delivery, and construction of deep-water risers, oil, and gas production, and receiving and processing facilities. In addition, the company provides offshore fish farming, carbon capture, utilization and storage, hydrogen, and offshore wind solutions. Further, the company designs and constructs jackets for construction services and offers electrification services; and designs and constructs offshore oil and gas production facilities and onshore receiving and processing facilities. Additionally, the company provides subsea production, compression, pump, power distribution, and processing systems, and subsea lifecycle services. Furthermore, the company offers maintenance, modifications, decommissioning, asset integrity management, hook-up, and completion solutions. Aker Solutions ASA was founded in 1841 and is headquartered in Fornebu, Norway.

Earnings Per Share

As for profitability, AKER SOLUTIONS has a trailing twelve months EPS of kr3.41.

PE Ratio

AKER SOLUTIONS has a trailing twelve months price to earnings ratio of 13.65. Meaning, the purchaser of the share is investing kr13.65 for every norwegian krone of annual earnings.

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 17.09%.

Moving Average

AKER SOLUTIONS’s worth is way higher than its 50-day moving average of kr39.50 and way above its 200-day moving average of kr38.75.

Yearly Top and Bottom Value

AKER SOLUTIONS’s stock is valued at kr46.56 at 02:20 EST, under its 52-week high of kr47.30 and way above its 52-week low of kr27.62.

Volume

Today’s last reported volume for AKER SOLUTIONS is 422526 which is 44.93% below its average volume of 767381.

More news about AKER SOLUTIONS.

Leave a Reply

Your email address will not be published. Required fields are marked *